| Literature DB >> 35003310 |
Huan Liang1, Yan Wu1, Wei Zhang2, Pin Deng1, Fa-Sen Huang1, Xin Du3, Zhao-Jun Chen2, Yu-Feng Ma2.
Abstract
BACKGROUND: Gouty arthritis is a common metabolic disease caused by long-term purine metabolism and elevated serum uric acid. In recent years, the incidence of gouty arthritis has been increasing year by year. As an effective method for treating gouty arthritis, acupuncture combined with herbal medicine has been widely used in clinical practice. However, the evidence for the treatment needs to be evaluated through systematic review and meta-analysis. Methods. The Cochrane Library, PubMed, Web of Science, EMBASE, China CBM database, Clinical Trials, CNKI, China Wanfang database, and VIP information database were searched from the establishment of each database to March 2021. Randomized controlled trials (RCTs) were included in the study, and the therapeutic effects of acupuncture combined with herbal medicine versus conventional therapy, or acupuncture combined with herbal medicine versus anti-inflammatory drugs, or acupuncture combined with herbal medicine versus acupuncture/herbal medicine alone were compared in the subjects with gouty arthritis. Two authors screened all references, assessed the risk of bias, and independently extracted the data. The binary outcome was summarized using 95% confidence intervals (CIs) and risk ratios (RRs). The overall quality of the evidence was assessed with hierarchy, and meta-analysis was performed with a random-effects model.Entities:
Year: 2021 PMID: 35003310 PMCID: PMC8736704 DOI: 10.1155/2021/8161731
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flow chart for the selection of trials. Flow diagram following the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement.
Characteristics of included randomized trials of acupuncture combined with herbal medicine for gouty arthritis.
| Study ID | Year | Gender male/female | Sample size | Age (mean or range, yrs) | Course of disease(mean or range) | Course of treatment, days | Intervention vs. control | Outcomes | Control measures |
|---|---|---|---|---|---|---|---|---|---|
| JinRT 2011 | 2011 | I:29/1 C:28/2 | I:30 C:30 | I:47.50 ± 10.29 C:43.37 ± 11.34 | I:17.62 ± 44.24 C:17.92 ± 35.0 | 10 | Acupuncture plus herbal medicine vs. benzbromarone | Clinical effect, UA, VAS | Benzbromarone: 1 time/day, 50 mg/time |
| liuF 2011 | 2011 | NR | I:34 C:36 | I:40∼60(52) C:40–60(52) | I:2 month-4 years C:2 month-4 years | 5 | Acupuncture plus herbal medicine vs. acupuncture | Clinical effect | Acupuncture: 1 time/day |
| liYM 2019 | 2019 | I:21/9 C:23/7 | I:30 C:30 | I:37∼72 C:35∼70 | I:3d-10 years C:7d-12 years | 10 | Acupuncture plus herbal medicine vs. benzbromarone | Clinical effect | Benzbromarone: 1 time/day, 50 mg/time |
| ZhongYH 2021 | 2021 | I:28/2 C:29/1 | I:30 C:30 | I:18–80 (42.33 ± 14.36) C:18–80 (39.30 ± 12.99) | NR | 14 | Acupuncture plus herbal medicine vs. febuxostat and colchicine | Clinical effect, UA, Scr, BUN, 24 hour urine protein, CRP, TCM score, AEs | Febuxostat: 1 time/day, 40 mg/time; colchicine: 3 times/day, 0.5 mg/time |
| FengPD 2017 | 2017 | I:22/9 C:12/3 | I:31 C:18 | I:22–71 C:31–73 | NR | 14 | Acupuncture plus herbal medicine vs. dafen capsules | Clinical effect | Dafen capsules: 1 time/day, 75 mg/time |
| ZhangSJ 2010 | 2010 | I:34/0 C:33/0 | I:34 C:33 | 32–71 48 | 7 day-14 years | 3–7 days | Acupuncture plus herbal medicine vs. diclofenac sodium enteric-coated tablets | Therapeutic effects | Diclofenac sodium enteric-coated tablets: 3 times/day, 25 mg/time |
| LiuZY 2014 | 2014 | NR | I:87 C:87 | I:44.1 C:43.4 | NR | 14 | Acupuncture plus herbal medicine vs. benzbromarone tablets | Clinicaleffect, CRP, BUA, ESR, VAS, AEs | Benzbromarone: 1 time/day, 50 mg/time |
| GuanFY 2014 | 2014 | I:28/2 C:29/1 | I:30 C:30 | I:31–72 (45.3 ± 6.17) C:28–70 (44.7 ± 6.40) C:1–10 (5.76 ± 3.77)years | I:0.5–11 (5.71 ± 3.72) years | 7 | Acupuncture plus herbal medicine vs. meloxicam and sodium bicarbonate tablets | Clinical effect, UA, VAS, | Meloxicam tablets: 1 time/day, 15 mg/time; sodium bicarbonate tablets: 3 times/day, 1 g/time |
| XieYF 2015 | 2015 | I:41/4 C:42/2 | I:45 C:44 | I:40–73 C:42–72 | I:1d-14 years C:2d-13 years | 7 | Fire acupuncture plus herbal medicine vs. diclofenac sodium enteric solution tablet and allopurinol tablet | Clinical effect, VAS, | Diclofenac sodium enteric-coated tablets: 1 time/day, 75–25 mg/time; allopurinol: 1 time/day, 50 mg/time |
| ChenKW 2016 | 2016 | I:47/31 C:48/30 | I:78 C:78 | I:(54.1 ± 7.7) C:53.9 ± 8.1 | I:(4.1 ± 1.3) years C:(3.9 ± 1.4) years | 7 | Acupuncture plus herbal medicine vs. diclofenac sodium sustained-release tablets and allopurinol tablets | Clinical effect, adverse triglycerides, cholesterol, high-density lipoprotein, low-density lipoprotein, and AEs | Diclofenac sodium sustained-release tablets: 1 time/day, 75 mg/time; allopurinol: 3 times/day, 100 mg/time |
| JinZ 2012 | 2012 | I:29/1 C:27/3 | I:30 C:30 | I:23–67 C:25–66 | NR | 7 | Acupuncture plus herbal medicine vs. gout tablets | Clinical effect, VAS, UA, AES | Gout tablets (Chinese patent medicine): 3 times/day, 0.12 g/time |
| liJY 2013 | 2013 | I:28/3 C:28/31 | I:31 C:29 | I:49.67 ± 9.33 C:46.53 ± 10.29 | I:4–11(7.1 ± 3.9)d C:2–10(6.7 ± 3.2)d | 21 | Acupuncture plus herbal medicine vs. colchicine vs. diclofenac sodium sustained-release tablets | Clinical effect, UA, AEs | Colchicine: 1 time/day, 0.5 g/time; diclofenac sodium sustained-release tablets: 1 times/day, 100 mg/time |
| WangMJ 2015 | 2015 | Male: 35 Female: 25 | I:20 C1:20 C2:20 | NR | 2–13 years |
| Acupuncture plus herbal medicine vs. Acupuncture vs. herbal medicine | Clinical effect, UA | Acupuncture: 1 time/day, herbal medicine 2 times/day |
| ZhuC 2011 | 2011 | I:30 C1:30 C2:30 | I:30 C1:30 C2:30 | I:48.12 ± 11.21 C1:47.44 ± 11.29 C2:50.36 ± 11.07 | I:25.52 ± 9.87 C1:24.16 ± 10.07 C2:26.04 ± 10.03 | 6 | Acupuncture plus herbal medicine vs. indomethacin vs. acupuncture | Clinical effect, UA, ESR, | Indomethacin: 3 times/day, 25 mg/time; herbal medicine: 3 time/day |
Note: NR: not reported; I: intervention; C: comparison; Y: yes; N: no; AEs: adverse effects; UA: uric acid; VAS: visual analogue scale; Scr: serum creatinine concentration; BUN: blood urea nitrogen; CRP: C-reactive protein; TCM: traditional Chinese medicine; BUA: blood uric acid; ESR: erythrocyte sedimentation rate; Yrs: years; vs: versus.
Details of intervention in acupuncture groups and control groups.
| Study ID | Acupuncture point [ | Acupuncture on one or both sides of the body | Duration of each treatment | Frequency | With or without conventional medicine |
|---|---|---|---|---|---|
| JinRT 2011 | Yinlingquan(SP9), Sanyinjiao(SP6), Zusanli(ST36), Quchi(LI11) | On both sides | 30 min | 1 time/day; | Y |
| liuF 2011 | Quchi(LI11), Hegu(LI4), Yinbai(SP1), Dadu(SP2), Sanyinjiao(SP6), Yinlingquan(SP9) | NR | 30 min | 1 time/day; | N |
| liYM 2019 | Taibai(Sp3), Taichong (Liv3), Xingjian(Liv2), Neiting (S44), Xiangu(S43), Qiuxu(G40), intense redness, swelling, and pain areas (usually the location of gouty tophus deposits) | NR | NR | 1 time every other day; | Y |
| ZhongYH 2021 | Local joint with recurrent gout | On one side | NR | Acupuncture:1 time; | Y |
| FengPD 2017 | The local tenderness point of the joint lesion and the surface of the distended and bruising vein | On one side | 3–5 min | 2 times/week | Y |
| ZhangSJ 2010 | Local joint with recurrent gout | NR | 2–5 min | 3 times/day | Y |
| LiuZY 2014 | Xuehai(SP10), Zusanli(ST36), Sanyinjiao (SP6), Fenglong(S40), Yinlingquan(SP9), Quchi(LI11), Hegu(LI4), Taichong (Liv3), Dadu(SP2), Local ashi point | NR | 30 min | 1 time/day | Y |
| GuanFY 2014 | Taichong (Liv3), Sanyinjiao(SP6), Zusanli(ST36), Fenglong(S40), Yinlingquan(SP9), Yanglingquan(GB34) | NR | 20 min | 1 time/day | Y |
| XieYF 2015 | Ashi point | NR | NR | 1 time/day | Y |
| ChenKW 2016 | Ashi point(Pain point), Zusanli(ST36), Sanyinjiao(SP6) | NR | 15 min | 1 time/day | Y |
| JinZ 2012 | Xuanzhong(G39), Sanyinjiao(SP6), Shangqiu(Sp5), Zhaohai(K6), Yanglingquan(GB34), Yinlingquan(SP9), Liangqiu(ST34), Xuehai(SP10), Quchi(LI11), Shaohai (H3), Shousanli(LI10), Chize(L15) | NR | NR | 1 time/day | N |
| liJY 2013 | Zusanli(ST36), Sanyinjiao(SP6), Yinlingquan(SP9), Fenglong(S40), Xuehai(SP10), Quchi(LI11), Hegu(LI4), Taichong (Liv3), ashi point | NR | 30 min | 1 time/day | Y |
| WangMJ 2015 | Zusanli(ST36), Sanyinjiao (SP6), Yinlingquan(SP9), Yanglingquan(GB34), Fenglong(S40), gongsun (SP 4) (both sides), Ashi point | On both sides | 30 min | NR | N |
| ZhuC 2011 | Yinbai(SP1), Taichong(Liv3), Sanyinjiao(SP6), Fenglong(S40), Zusanli(ST36), Yinlingquan(SP9), Yanglingquan(GB34), Taibai(Sp3), Hegu(LI4), ashi point | NR | 30 | 1 time every other day; | Y |
| Yinlingquan(SP9), Sanyinjiao(SP6), Zusanli(ST36), Quchi(LI11) | On both sides |
Note: NR: not reported; Y: yes; N: no.
Figure 2Risk of bias of randomized clinical trials of acupuncture combined with herbal medicine for gouty arthritis. Note: A: Selection bias; B: selection bias C; performance bias of participants and personnel; D: detection bias; E: attrition bias; F: reporting bias; and G: other biases.
Figure 3Clinical effect of acupuncture combined with herbal medicine versus conventional medicine.
Figure 4Clinical effect of acupuncture combined with herbal medicine versus acupuncture alone.
Figure 5Clinical effect of acupuncture combined with herbal medicine versus herb alone.
Figure 6Clinical effect of acupuncture combined with herbal medicine versus anti-inflammatory medications.
Figure 7Clinical effect of acupuncture combined with herbal medicine versus colchicine.
Figure 8Uric acid of acupuncture combined with herbal medicine versus acupuncture alone.
Figure 9VAS of acupuncture combined with herbal medicine versus anti-inflammatory medications.
Figure 10Adverse events of acupuncture combined with herbal medicine compared to conventional medicine.
Figure 11Trim-and-fill analysis for the comparison of clinical treatment efficacy between acupuncture combined with herbal medicine and conventional therapy.